Press Release: InterveXion : InterveXion Enrolls First Patient in Meth-OD, a Phase 2 Study of IXT-m200 in Methamphetamine Overdose

First clinical trial specifically for patients suffering from methamphetamine overdose LITTLE ROCK, AR, USA, September 20, 2021 /⁨EINPresswire.com⁩/ -- InterveXion Therapeutics, a clinical-stage biopharmaceutical company, today announced the enrollment of ...